At a glance
(in thousands of €, if not stated otherwise) |
31/03/2017 |
31/03/2016 |
Results |
|
|
Revenues and other income |
39,863 |
14,817 |
R&D expenditure |
(44,930) |
(27,818) |
S, G&A expenses |
(6,158) |
(4,394) |
Personnel expenses (including share-based compensation) |
(16,280) |
(11,251) |
Capital expenditure |
1,036 |
1,065 |
Depreciation and amortization of (in)tangible assets |
(1,050) |
(964) |
Operating loss |
(11,225) |
(17,395) |
Net financial results |
(2,380) |
53,345 |
Taxes |
– |
– |
Net income / loss (–) |
(13,605) |
35,950 |
Galapagos share |
|
|
Number of shares issued on 31 March |
46,256,078 |
45,837,043 |
Basic income / loss (–) per share (in €) |
(0.29) |
0.81 |
Diluted income / loss (–) per share (in €) |
(0.29) |
0.79 |
Share price on 31 March (in €) |
81.58 |
36.99 |
Personnel data |
|
|
Total group employees on 31 March (number) |
530 |
447 |
(thousands of €) |
31/03/2017 |
31/12/2016 |
Total assets |
1,072,814 |
1,083,338 |
Cash, cash equivalents and restricted cash |
958,557 |
980,909 |
Total liabilities |
324,665 |
324,637 |
Stockholders' equity |
748,150 |
758,701 |
Employees per site as of 31 March 2017
